These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson's Disease: Clinical Trial Post Hoc Analyses. Pahwa R; Aldred J; Gupta N; Terasawa E; Garcia-Horton V; Steffen DR; Kandukuri PL; Chaudhari VS; Jalundhwala YJ; Bao Y; Kukreja P; Isaacson SH Neurol Ther; 2022 Jun; 11(2):711-723. PubMed ID: 35192177 [TBL] [Abstract][Full Text] [Related]
4. Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa. Othman AA; Rosebraugh M; Chatamra K; Locke C; Dutta S J Parkinsons Dis; 2017; 7(2):275-278. PubMed ID: 28211816 [TBL] [Abstract][Full Text] [Related]
5. Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson's Disease in the United States. Amjad F; Bhatti D; Davis TL; Oguh O; Pahwa R; Kukreja P; Zamudio J; Metman LV Adv Ther; 2019 Sep; 36(9):2233-2246. PubMed ID: 31278691 [TBL] [Abstract][Full Text] [Related]
6. Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study. Zulli C; Sica M; De Micco R; Del Prete A; Amato MR; Tessitore A; Ferraro F; Esposito P Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2413-7. PubMed ID: 27338069 [TBL] [Abstract][Full Text] [Related]
7. Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safety. Othman AA; Chatamra K; Mohamed ME; Dutta S; Benesh J; Yanagawa M; Nagai M Clin Pharmacokinet; 2015 Sep; 54(9):975-84. PubMed ID: 25875940 [TBL] [Abstract][Full Text] [Related]
8. Duopa--a carbidopa/levodopa enteral suspension for Parkinson's disease. Med Lett Drugs Ther; 2015 Aug; 57(1474):112. PubMed ID: 26218794 [No Abstract] [Full Text] [Related]
9. Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients. Antonini A; Fung VS; Boyd JT; Slevin JT; Hall C; Chatamra K; Eaton S; Benesh JA Mov Disord; 2016 Apr; 31(4):530-7. PubMed ID: 26817533 [TBL] [Abstract][Full Text] [Related]